\
&
Contact us
\
&
Contact us
Published on | 1 year ago
Programmes ERC ERCPrincipal Investigators with a main European Research Council grant that is ongoing or ended after 1 January 2023 are eligible to participate in an ERC 2024 Proof of Concept Grant. The ERC Proof of Concept Grants aim at facilitating exploration of the commercial and social innovation potential of ERC funded research and are therefore available only to PIs whose proposals draw substantially on their ERC funded research. For the 2024 Proof of Concept call (1st cut-off deadline 14 March 2024) in total 100 ERC Proof of Concept Grants were awarded, of which five to researchers based at a Flemish host institution. The ERCEA news article contains all funded projects including the 2000th awarded ERC Proof of Concept grant to the project DeepSpacePULSE (ICE-CSIC news article).
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
